H Arima

Author PubWeight™ 52.36‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomised trials. BMJ 2008 6.13
2 Effects of blood pressure lowering on cardiovascular risk according to baseline body-mass index: a meta-analysis of randomised trials. Lancet 2014 2.18
3 Trends in prevalence of Alzheimer's disease and vascular dementia in a Japanese community: the Hisayama Study. Acta Psychiatr Scand 2010 1.45
4 Incidence and risk factors for subtypes of cerebral infarction in a general population: the Hisayama study. Stroke 2000 1.39
5 Impact of Helicobacter pylori infection on gastric cancer incidence in a general Japanese population: the Hisayama study. Arch Intern Med 2000 1.24
6 APOE genotype, ethnicity, and the risk of cerebral hemorrhage. Neurology 2008 1.24
7 Lymphatic invasion using D2-40 monoclonal antibody and its relationship to lymph node micrometastasis in pN0 gastric cancer. Br J Cancer 2005 1.20
8 The second (main) phase of an open, randomised, multicentre study to investigate the effectiveness of an intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT2). Int J Stroke 2010 1.17
9 Incidence and survival of dementia in a general population of Japanese elderly: the Hisayama study. J Neurol Neurosurg Psychiatry 2008 1.11
10 Impact of antihypertensive medication adherence on blood pressure control in hypertension: the COMFORT study. QJM 2013 0.98
11 Mice transgenically overexpressing sulfonylurea receptor 1 in forebrain resist seizure induction and excitotoxic neuron death. Proc Natl Acad Sci U S A 2001 0.98
12 Controlled release of a water-soluble drug, captopril, by a combination of hydrophilic and hydrophobic cyclodextrin derivatives. J Control Release 2000 0.94
13 Blood vitamin B1, transketolase and thiamine pyrophosphate (TPP) effect in beriberi patients, with studies employing discriminant analysis. Clin Chim Acta 1980 0.93
14 Reduction of insulin signaling upregulates angiopoietin-like protein 4 through elevated free fatty acids in diabetic mice. Exp Clin Endocrinol Diabetes 2011 0.93
15 Neuropeptide FF reduces food intake in rats. Peptides 1996 0.89
16 Characterization of itraconazole/2-hydroxypropyl-beta-cyclodextrin inclusion complex in aqueous propylene glycol solution. Int J Pharm 1999 0.85
17 Role of endogenous nociceptin in the regulation of arginine vasopressin release in conscious rats. Endocrinology 2000 0.85
18 Anorectic effect of pituitary adenylate cyclase activating polypeptide (PACAP) in rats: lack of evidence for involvement of hypothalamic neuropeptide gene expression. J Neuroendocrinol 1998 0.84
19 Contribution of CR3 to nitric oxide production from macrophages stimulated with high-dose of LPS. Biochem Biophys Res Commun 1998 0.83
20 Effects of acute hypotensive stimuli on arginine vasopressin gene transcription in the rat hypothalamus. Am J Physiol Endocrinol Metab 2000 0.83
21 Intracerebroventricular injection of adrenomedullin inhibits vasopressin release in conscious rats. Neurosci Lett 1996 0.82
22 Lower blood pressure and risk of recurrent stroke in patients with chronic kidney disease: PROGRESS trial. Kidney Int 2008 0.81
23 Improvement of subcutaneous bioavailability of insulin by sulphobutyl ether beta-cyclodextrin in rats. J Pharm Pharmacol 2000 0.81
24 Improvement of some pharmaceutical properties of DY-9760e by sulfobutyl ether beta-cyclodextrin. Int J Pharm 2001 0.81
25 Improvement of solubility and oral bioavailability of rutin by complexation with 2-hydroxypropyl-beta-cyclodextrin. Pharm Dev Technol 2000 0.80
26 Efficient gene transfer to EGF receptor overexpressing cancer cells by means of EGF-labeled cationic liposomes. Biochem Biophys Res Commun 1996 0.80
27 Solid-state 13C nuclear magnetic resonance spectroscopic study on amorphous solid complexes of tolbutamide with 2-hydroxypropyl-alpha- and -beta-cyclodextrins. Pharm Res 1999 0.80
28 Liposomal induction of a heat-stable macrophage priming factor to induce nitric oxide in response to LPS. Pharm Res 1996 0.80
29 Induction of apoptosis in WEHI 231 cells by cationic liposomes. Pharm Res 2000 0.79
30 Protective effect of sulfobutyl ether beta-cyclodextrin on DY-9760e-induced hemolysis in vitro. J Pharm Sci 2002 0.79
31 Negatively charged liposomes inhibit tyrosine phosphorylation of 41-kDa protein in murine macrophages stimulated with LPS. Biochem Biophys Res Commun 1997 0.78
32 The expression of pituitary adenylate cyclase-activating polypeptide (PACAP) mRNA in rat brain: possible role of endogenous PACAP in vasopressin release. Neurosci Lett 1995 0.78
33 Improvement of dermatitis by iontophoretically delivered antisense oligonucleotides for interleukin-10 in NC/Nga mice. Gene Ther 2004 0.78
34 Analysis of the phase solubility diagram of a phenacetin/competitor/beta-cyclodextrin ternary system, involving competitive inclusion complexation. Chem Pharm Bull (Tokyo) 2001 0.78
35 Stereoselectivity of a potent calcium antagonist, 1-benzyl-3-pyrrolidinyl methyl 2,6-dimethyl-4-(m-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate. J Med Chem 1986 0.78
36 Imidazo[2,1-b]benzothiazoles. 2. New immunosuppressive agents. J Med Chem 1986 0.78
37 Analysis of the vasopressin system and water regulation in genetically polydipsic mice. Am J Physiol Endocrinol Metab 2000 0.78
38 Dynamic SPECT evaluation of renal plasma flow using technetium-99m MAG3 in kidney transplant patients. J Nucl Med Technol 1999 0.78
39 Age-associated decrease in response of rat aquaporin-2 gene expression to dehydration. Life Sci 1998 0.78
40 Hydrolysis behavior of prednisolone 21-hemisuccinate/beta-cyclodextrin amide conjugate: involvement of intramolecular catalysis of amide group in drug release. Chem Pharm Bull (Tokyo) 2000 0.78
41 Stabilizing and solubilizing effects of sulfobutyl ether beta-cyclodextrin on prostaglandin E1 analogue. Pharm Res 2001 0.78
42 Effects of low estimated glomerular filtration rate on outcomes after stroke: a hospital-based stroke registry in China. Eur J Neurol 2013 0.77
43 Release characteristics of a short-chain fatty acid, n-butyric acid, from its beta-cyclodextrin ester conjugate in rat biological media. J Pharm Sci 2000 0.77
44 Heptakis(2,6-di-O-methyl-3-O-acetyl)-beta-cyclodextrin: A water-soluble cyclodextrin derivative with low hemolytic activity. J Pharm Sci 1999 0.77
45 A moderate interaction of maltosyl-alpha-cyclodextrin with Caco-2 cells in comparison with the parent cyclodextrin. Biol Pharm Bull 2001 0.77
46 Prednisolone-appended alpha-cyclodextrin: alleviation of systemic adverse effect of prednisolone after intracolonic administration in 2,4,6-trinitrobenzenesulfonic acid-induced colitis rats. J Pharm Sci 2001 0.76
47 Preparation of prednisolone-appended alpha-, beta- and gamma-cyclodextrins: substitution at secondary hydroxyl groups and in vitro hydrolysis behavior. J Pharm Sci 2001 0.76
48 Scavenger receptors may regulate nitric oxide production from macrophages stimulated by LPS. Biochem Biophys Res Commun 1997 0.76
49 Adaptation to sustained high plasma vasopressin in water and electrolyte homeostasis in the rat transgenic for the metallothionein-vasopressin fusion gene. J Endocrinol 2002 0.76
50 Hemoperitoneum secondary to exophytic leiomyoma: report of a case. Surg Today 2000 0.76
51 Protective effect of hedgehog signaling on cytokine-induced cytotoxicity in pancreatic beta-cells. Exp Clin Endocrinol Diabetes 2010 0.76
52 Enhanced absorption of cyclosporin A by complexation with dimethyl-beta-cyclodextrin in bile duct-cannulated and -noncannulated rats. Biol Pharm Bull 1999 0.76
53 Antiserum against neuropeptide FF augments vasopressin release in conscious rats. Peptides 1998 0.75
54 [Studies on the syntheses of 2(1H)-pyridone derivatives. I. Synthesis and pharmacological property of 6-substitued 2(1H)-pyridones (author's transl)]. Yakugaku Zasshi 1979 0.75
55 X-ray crystallographic characterization of nilvadipine monohydrate and its phase transition behavior. Eur J Pharm Sci 2000 0.75
56 [Effects of the newly developed mandibular retraction system in a rat]. Nichidai Koko Kagaku 1990 0.75
57 [Circulatory symptoms in multiple sclerosis--a case with transient hypertension, tachycardia and subendocardial infarction]. Nihon Rinsho 1980 0.75
58 [Clinical studies of childhood empyema experienced for the past 12 years (author's transl)]. Kansenshogaku Zasshi 1978 0.75
59 Formation of NaCl-type monodeuteride LaD by the disproportionation reaction of LaD2. Phys Rev Lett 2012 0.75
60 Macrosialin may not be involved with the regulation of nitric oxide production from mouse peritoneal macrophages stimulated with LPS. Res Commun Mol Pathol Pharmacol 1999 0.75
61 Overexpression of vasopressin in the rat transgenic for the metallothionein-vasopressin fusion gene. J Endocrinol 2002 0.75
62 [Autopsy case of Simmonds' syndrome]. Horumon To Rinsho 1971 0.75
63 Effect of 2-hydroxypropyl-beta-cyclodextrin on percutaneous absorption of methyl paraben. J Pharm Pharmacol 1995 0.75
64 [Acute myelogenous leukemia with spontaneous remission simultaneous with improvement of severe infection: report of 2 cases]. Nihon Naika Gakkai Zasshi 1999 0.75
65 Effects of aging on crystallization, dissolution and absorption characteristics of amorphous tolbutamide-2-hydroxypropyl-beta-cyclodextrin complex. Chem Pharm Bull (Tokyo) 2000 0.75
66 [Latent thoracic empyema--with special reference to the developmental mechanism of lung fistula from pleural callosity diagnosed by thoracic radiography]. Bull Chest Dis Res Inst Kyoto Univ 1972 0.75
67 [Pharmacokinetic study of UFT in cancer patients receiving maintenance dialysis]. Gan To Kagaku Ryoho 1995 0.75
68 Roentgeno-histological studies on serial alveolography. Tohoku J Exp Med 1978 0.75
69 [Possible utility of beta-cyclodextrin complexation in the preparation of biphenyl acetic acid suppositories]. Yakugaku Zasshi 1986 0.75
70 Central administration of urocortin inhibits vasopressin release in conscious rats. Neurosci Lett 1998 0.75
71 A cubic-anvil high-pressure device for pulsed neutron powder diffraction. Rev Sci Instrum 2010 0.75
72 Determination of stability constant of beta-cyclodextrin complexes using the membrane permeation technique and the permeation behavior of drug-competing agent-beta-cyclodextrin ternary systems. Eur J Pharm Sci 1999 0.75
73 [Morphology of occlusal plane--contact of occlusal plane]. Shikai Tenbo 1978 0.75
74 Higher mortality in patients with right hemispheric intracerebral haemorrhage: INTERACT1 and 2. J Neurol Neurosurg Psychiatry 2015 0.75
75 [Evaluation on the difference in Vordere Asthöhe between the sexes and among normal occlusion, Class II division 1 malocclusion, and true-Class III malocclusion]. Nichidai Koko Kagaku 1987 0.75
76 Effect of cyclodextrins on transthyretin amyloid formation in transthyretin-related amyloidosis. Amyloid 2011 0.75
77 [Histological investigations on the effect of the retraction apparatus applied to the rat]. Nihon Kyosei Shika Gakkai Zasshi 1988 0.75
78 [Removal of a foreign object (gauze) following thoracic surgery]. Kyobu Geka 1976 0.75
79 Sustained release of buserelin acetate, a luteinizing hormone-releasing hormone agonist, from an injectable oily preparation utilizing ethylated beta-cyclodextrin. J Pharm Pharmacol 1989 0.75